Myositis Interstitial Lung Disease Nintedanib Trial

Clinical trial NCT05799755 · COMPLETED

Trial details

NCT number: NCT05799755
Sponsor: Rohit Aggarwal, MD
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Myositis Associated Interstitial Lund Disease (MA-ILD)

Start date: 2023-08-01
Primary completion: 2025-03-17
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.